MIRA
INFORM REPORT
|
Report Date : |
23.09.2011 |
IDENTIFICATION DETAILS
|
Name : |
SWETA PHARMA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Dalamal House, 4th Floor, Nariman Point, Mumbai – 400021, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2010 |
|
|
|
|
Date of
Incorporation : |
19.06.1981 |
|
|
|
|
Com. Reg. No.: |
11-24656 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.0.222 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239MH1981PTC024656 |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Importer and Trader of Pharmaceuticals Raw Material and
Excipients Products. |
|
|
|
|
No. of Employees
: |
09 (In office) |
RATING & COMMENTS
|
MIRA’s Rating : |
B (28) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 7000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having moderate track records. The
company management has confirmed that there is a dip in the turnover in the year
2010-2011, because they had concentrated more on the joint venture. Trade
relations are reported as fair. Business is active. Payments are reported to
be slow but correct. The company can be considered for business dealings with some caution. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
INFORMATION PARTED BY
|
Name : |
Mr. C V Khimani |
|
Designation : |
Accounts Manager |
|
Contact No.: |
91-9819792370 |
|
Date : |
22.09.2011 |
LOCATIONS
|
Registered Office : |
Dalamal House, 4th Floor, Nariman Point, Mumbai – 400021, |
|
Tel. No.: |
91-22-22010336 |
|
Fax No.: |
91-22-22076974 |
|
E-Mail : |
|
|
Area : |
1100sq.fts |
|
Location: |
Owned |
|
|
|
|
Corporate office : |
11, Mansoor Building, 98, |
|
Location: |
Owned |
DIRECTORS
AS ON 30.09.2010
|
Name : |
Mr. Manish Umed Doshi |
|
Designation : |
Director |
|
Address : |
1202, Chandan Bala Apartments, 4, R.R. Thakkar Marg, Walkeshwar,
Mumbai – 400006, |
|
Date of Birth/Age : |
07.10.1961 |
|
Date of Appointment : |
12.08.1997 |
|
DIN No. : |
00210389 |
Directors Profile:
|
S.No. |
CIN |
Name of the
Company |
Current
designation of the director |
Date of
appointment at current designation |
Original date
of appointment |
Date of cessation |
Company Status |
Defaulting
status |
|
1 |
U24231GJ1982PTC004950 |
UMEDICA LABORATORIES
PRIVATE LIMITED |
Director |
05/01/1982 |
05/01/1982 |
- |
Active |
NO |
|
2 |
U67120MH1991PTC060393 |
TOLSTOY INVESTMENTS
Private Limited |
Director |
19/03/1991 |
19/03/1991 |
- |
Active |
NO |
|
3 |
U24231GJ1991PTC016288 |
AMOLI ORGANICS PRIVATE
LIMITED |
Director |
15/10/1994 |
15/10/1994 |
- |
Active |
|
|
4 |
U99999MH1958PTC011058 |
URANUS ELECTRO TECHNIK
PRIVATE LIMITED |
Director |
10/07/1995 |
10/07/1995 |
- |
Active |
NO |
|
5 |
U24239MH1981PTC024656 |
SWETA PHARMA PVT LTD |
Director |
12/08/1997 |
12/08/1997 |
- |
Active |
NO |
|
6 |
U24117GJ1999PTC035456 |
SUJAG FINE CHEMICALS
PRIVATE LIMITED |
Director |
19/02/1999 |
19/02/1999 |
- |
Active |
NO |
|
7 |
U24239MH1989PTC051908 |
AGRIGUARD MANUFACTURING
PRIVATE LIMITED |
Director |
27/12/1999 |
27/12/1999 |
- |
Active |
NO |
|
8 |
U24231GJ1988PTC010742 |
BROMOFINE CHEM PRIVATE
LIMITED |
Director |
26/12/2000 |
26/12/2000 |
- |
Active |
NO |
|
9 |
U72900MH2004PTC144104 |
AMOLI INFOTECH PRIVATE
LIMITED |
Director |
20/01/2004 |
20/01/2004 |
- |
Active |
NO |
|
10 |
U51909MH2003PTC142648 |
KMI BUSINESS TECHNOLOGIES
PRIVATE LIMITED |
Director |
17/08/2004 |
17/08/2004 |
- |
Active |
NO |
|
11 |
L45200PN1991PLC129428 |
KOLTE-PATIL DEVELOPERS
LIMITED |
Director |
04/07/2007 |
26/12/2006 |
- |
Active |
NO |
|
12 |
U67110MH2009PTC191826 |
AMOLI INVESTMENT SERVICES
PRIVATE LIMITED |
Director |
18/04/2009 |
18/04/2009 |
- |
Active |
NO |
|
13 |
U70102MH2009PTC191879 |
AMOLI PROPERTIES PRIVATE
LIMITED |
Director |
21/04/2009 |
21/04/2009 |
- |
Active |
NO |
|
14 |
U70102MH2009PTC192006 |
UMEDICA PROPERTIES PRIVATE
LIMITED |
Director |
24/04/2009 |
24/04/2009 |
- |
Active |
NO |
|
15 |
U67100MH2009PTC192008 |
UMEDICA INVESTMENT
SERVICES PRIVATE LIMITED |
Director |
24/04/2009 |
24/04/2009 |
- |
Active |
NO |
|
16 |
U85199PN2005PTC020895 |
STEMONE BIOLOGICALS PRIVATE
LIMITED |
Director |
26/06/2010 |
26/06/2010 |
- |
Active |
NO |
|
Name : |
Mrs. Vandana Manish Doshi |
|
Designation : |
Director |
|
Address : |
1202, Chandan Bala Apartments, 4, R.R. Thakkar Marg, Walkeshwar,
Mumbai – 400006, |
|
Date of Birth/Age : |
23.08.1962 |
|
Date of Appointment : |
20.03.1985 |
|
DIN No. : |
00211618 |
Directors Profile:
|
S.No. |
CIN |
Name of the
Company |
Current
designation of the director |
Date of appointment
at current designation |
Original date
of appointment |
Date of
cessation |
Company Status |
Defaulting
status |
|
1 |
U24239MH1981PTC024656 |
SWETA PHARMA PVT LTD |
Director |
20/03/1985 |
20/03/1985 |
- |
Active |
NO |
|
2 |
U67120MH1991PTC060393 |
TOLSTOY INVESTMENTS
Private Limited |
Director |
19/03/1991 |
19/03/1991 |
- |
Active |
NO |
|
3 |
U24231GJ1991PTC016288 |
AMOLI ORGANICS PRIVATE
LIMITED |
Director |
19/09/1991 |
19/09/1991 |
- |
Active |
|
|
4 |
U99999MH1978PTC020156 |
URANUS ELECTRONICS PRIVATE
LIMITED |
Director |
07/03/1996 |
07/03/1996 |
- |
Active |
NO |
|
5 |
U72900MH2004PTC144104 |
AMOLI INFOTECH PRIVATE
LIMITED |
Director |
20/01/2004 |
20/01/2004 |
- |
Active |
NO |
|
6 |
U67190MH2005PTC155528 |
APE-AAN FINSER PRIVATE
LIMITED |
Director |
22/08/2005 |
22/08/2005 |
- |
Active |
NO |
|
7 |
U67110MH2009PTC191826 |
AMOLI INVESTMENT SERVICES
PRIVATE LIMITED |
Director |
18/04/2009 |
18/04/2009 |
- |
Active |
NO |
|
8 |
U70102MH2009PTC191879 |
AMOLI PROPERTIES PRIVATE
LIMITED |
Director |
21/04/2009 |
21/04/2009 |
- |
Active |
NO |
|
9 |
U70102MH2009PTC192006 |
UMEDICA PROPERTIES PRIVATE
LIMITED |
Director |
24/04/2009 |
24/04/2009 |
- |
Active |
NO |
|
10 |
U67100MH2009PTC192008 |
UMEDICA INVESTMENT
SERVICES PRIVATE LIMITED |
Director |
24/04/2009 |
24/04/2009 |
- |
Active |
NO |
|
Name : |
Mr. Bimal Kumar Shantilal Doshi |
|
Designation : |
Director |
|
Address : |
Chandan Bala Apartments, 4, R.R. Thakkar Marg, Walkeshwar, Mumbai –
400006, |
|
Date of Birth/Age : |
24.01.1964 |
|
Date of Appointment : |
02.09.2003 |
|
DIN No. : |
00978718 |
Directors Profile:
|
S.No. |
CIN |
Name of the
Company |
Current
designation of the director |
Date of
appointment at current designation |
Original date
of appointment |
Date of
cessation |
Company Status |
Defaulting
status |
|
1 |
U24239MH1981PTC024656 |
SWETA PHARMA PVT LTD |
Director |
02/09/2003 |
02/09/2003 |
- |
Active |
NO |
|
2 |
U24230MH2003PTC142463 |
NOVO EXCIPIENTS PRIVATE
LIMITED |
Director |
14/06/2011 |
14/06/2011 |
- |
Active |
NO |
KEY EXECUTIVES
|
Name : |
Mr. C V Khimani |
|
Designation : |
Accounts Manager |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 30.09.2010
|
Names of Shareholders |
|
No. of Shares |
|
Ramesh B. Doshi |
|
1 |
|
Vinod B. Doshi |
|
1 |
|
Navin V. Doshi |
|
1 |
|
|
|
5 |
|
Vandana M. Doshi |
|
1702 |
|
Umed B. Doshi |
|
10 |
|
Amoli M. Doshi |
|
200 |
|
Manish U. Doshi |
|
100 |
|
Manish U. Doshi (HUF) |
|
100 |
|
|
|
100 |
|
Total |
|
2220 |
AS ON 30.09.2010
|
Category |
Percentage |
|
Directors or relatives of Directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Importer and Trader of Pharmaceuticals Raw Material and
Excipients Products. |
|
|
|
|
Imports : |
|
|
Products : |
Pharmaceuticals Raw Material |
|
Countries : |
· China · Italy · Germany · Japan |
|
|
|
|
Terms : |
|
|
Selling : |
Cash, Credit |
|
|
|
|
Purchasing : |
L/C, DA |
GENERAL INFORMATION
|
Suppliers : |
·
Kenko Corporation, Japan ·
Ercros Int-Suffice, Italy |
||||||||||||
|
|
|
||||||||||||
|
Customers : |
·
Wholesalers ·
Retailers ·
Ketan Pharma ·
Allcare Laboratories ·
Pragati Chem Impex Private Limited |
||||||||||||
|
|
|
||||||||||||
|
Bankers : |
Indian Overseas Bank, Merchant Chamber, Ground Floor, |
||||||||||||
|
|
|
||||||||||||
|
Facilities : |
CC – 0.500 Million, LC – Rs.8.000 Millions
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Pradip Shah and Associates Chartered Accountant |
|
Address : |
F. No. 4, Sunbean Chambers, Sir V. Thakersey Marg, Marine Lines,
Mumbai – 400020, Maharashtra, India |
|
Tel. No.: |
91-22-66550627 / 28 |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
5000 |
Equity Shares |
Rs.100/- each |
Rs.0.500 Million |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
2220 |
Equity Shares |
Rs.100/-each |
Rs.0.222
Million |
FINANCIAL DATA
[all figures are
in Rupees Millions]
|
Particulars |
|
|
31.03.2011 |
|
Sales Turnover (Approximately) |
|
|
20.000 |
The above information has been parted by Mr. C V Khimani (Accounts
Manager)
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
0.222 |
0.222 |
0.222 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
1.492 |
0.032 |
0.530 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
1.714 |
0.254 |
0.752 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
11.569 |
5.873 |
4.227 |
|
|
TOTAL BORROWING |
11.569 |
5.873 |
4.227 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
13.283 |
6.127 |
4.979 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
0.352 |
0.406 |
0.083 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.010 |
0.010 |
0.010 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
2.513
|
5.908 |
5.879 |
|
|
Sundry Debtors |
11.837
|
13.184 |
12.486 |
|
|
Cash & Bank Balances |
0.052
|
0.250 |
0.064 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
18.741
|
9.467 |
6.227 |
|
Total
Current Assets |
33.143
|
28.809 |
24.656 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
17.305
|
20.916 |
17.731 |
|
|
Other Current Liabilities |
2.134
|
1.804 |
1.140 |
|
|
Provisions |
0.783
|
0.378 |
0.629 |
|
Total
Current Liabilities |
20.222
|
23.098 |
19.770 |
|
|
Net Current Assets |
12.921
|
5.711 |
4.886 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
13.283 |
6.127 |
4.979 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
|
|
|
|
|
|
Other Income |
|
|
|
|
|
|
TOTAL |
|
54.082 |
58.475 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Office Expenses |
|
|
|
|
|
|
Administrative Expenses |
|
|
|
|
|
|
Advertising Expenses |
|
|
|
|
|
|
TOTAL |
|
52.195 |
58.936 |
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
|
1.887 |
(0.461) |
|
|
|
|
|
|
|
|
|
Less |
TAX |
|
0.427 |
0.037 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX |
|
1.460 |
(0.498) |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
|
44.041 |
56.408 |
|
|
TOTAL EARNINGS |
|
44.041 |
56.408 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
PAT / Total Income |
(%) |
2.70
|
(0.85) |
-- |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
5.63
|
(1.58) |
-- |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
1.10
|
(1.81) |
-- |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
18.54
|
114.06 |
31.91 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.64
|
1.25 |
1.25 |
LOCAL AGENCY FURTHER INFORMATION
SUNDRY CREDITORS
DETAILS:
(Rs.
In Millions)
|
Particulars |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
Sundry Creditors – Others |
17.305
|
20.916 |
17.731 |
|
Check List by
Info Agents |
Available in
Report (Yes / No) |
|
1) Year of Establishment |
Yes |
|
2) Locality of the firm |
Yes |
|
3) Constitutions of the firm |
Yes |
|
4) Premises details |
Yes |
|
5) Type of Business |
Yes |
|
6) Line of Business |
Yes |
|
7) Promoter's background |
-- |
|
8) No. of employees |
Yes |
|
9) Name of person contacted |
Yes |
|
10) Designation of contact person |
Yes |
|
11) Turnover of firm for last three years |
Yes |
|
12) Profitability for last three years |
No |
|
13) Reasons for variation <> 20% |
No |
|
14) Estimation for coming financial year |
No |
|
15) Capital in the business |
Yes |
|
16) Details of sister concerns |
Yes |
|
17) Major suppliers |
Yes |
|
18) Major customers |
Yes |
|
19) Payments terms |
Yes |
|
20) Export / Import details (if
applicable) |
Yes |
|
21) Market information |
-- |
|
22) Litigations that the firm / promoter
involved in |
-- |
|
23) Banking Details |
Yes |
|
24) Banking facility details |
Yes |
|
25) Conduct of the banking account |
-- |
|
26) Buyer visit details |
-- |
|
27) Financials, if provided |
-- |
|
28) Incorporation details, if applicable |
-- |
|
29) Last accounts filed at ROC |
-- |
|
30) Major Shareholders, if available |
-- |
NOTE:
As informed Mr. Khemani, that company has done joint venture with Nova
Mumbai Excipients Private Limited from 2007.
FORM 8 :
|
Corporate
identity number of the company |
U24239MH1981PTC024656 |
|
Name of the
company |
SWETA PHARMA PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in |
Dalamal House, 4th Floor, Nariman Point, Mumbai – 400021, |
|
This form is for |
Creation
of charge |
|
Type of charge |
Book Debts Movable property |
|
Particular of
charge holder |
Indian Overseas Bank, Merchant Chamber, Ground Floor, |
|
Nature of
instrument creating charge |
Letter of
Hypothecation (For securing Machineries/Vehicles/Goods/Book-Debts). |
|
Date of
instrument Creating the charge |
26.04.2011 |
|
Amount secured by
the charge |
Rs.8.000 Millions |
|
Brief of the principal
terms an conditions and extent and operation of the charge |
Rate of interest
: Cash Credit: Base
Rate + 3.75%. Terms of
repayment : As per Sanction
Letter. Margin : Letter of
Credit-Inland and Foreign (DP/DA upto 90 days) :- 25% Sublimit- Clean
Cash Credit against Stock and Book Debts (upto 60 days) :- 25% on Stock and
50% on Book Debts. Extent and
operation of the charge : Exclusive charge
by hypothecation of Documents of title to goods /accepted hundies / stock / Book
debts present and future. Others : Letter of Credit
facility of Rs. 8.000 millions with sub-limit Clean Cash Credit of Rs. 0.500
million.. |
|
Short particulars
of the property or asset(s) charged (including complete address and location
of the property) |
Exclusive charge
by hypothecation of Documents of title to goods /accepted hundies / stock /
Book debts present & future |
TRADE REFERENCES:
·
Ketan Pharma
·
All Care Laboratories
FIXED ASSETS
- Air conditioner
- Motor Car
- Computer
- Fax Machine
- Printer
- Vehicle
- Tea Machine
- Furniture
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] on Violation of
Anti-Corruption Laws :
Charges or investigation
registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.48.82 |
|
|
1 |
Rs.75.48 |
|
Euro |
1 |
Rs.66.10 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
4 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILIRY |
1~10 |
2 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
3 |
|
--CREDIT LINES |
1~10 |
2 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
28 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.